 HIGHLANDS RANCH, Colo., Oct. 18, 2021 GLOBE NEWSWIRE -- Vivos Therapeutics, Inc. Vivos or the Company NASDAQ: VVOS, a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea OSA and snoring, and Candid Care Co. Candid , a digital platform for oral healthcare, today announced a new collaboration that will seek to provide patients with a comprehensive, whole-mouth solution to diagnose and treat OSA in adult patients and provide orthodontic treatment from the same provider network. 